As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
India in the Changing Landscape of Life-Sciences Research & Development
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Subscribe To Our Newsletter & Stay Updated
